NCT00834353View on ClinicalTrials.gov

Prospective Study of N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) Gene as Susceptible Risk Factors for Antituberculosis (ATT) Induced Hepatitis

CompletedOBSERVATIONAL
Timeline

Start Date

September 30, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

September 30, 2008

Conditions
Pulmonary Tuberculosis
Interventions
DRUG

ATT

Trial Locations (1)

110002

Premashis Kar, New Delhi

All Listed Sponsors
lead

Maulana Azad Medical College

OTHER

NCT00834353 - Prospective Study of N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) Gene as Susceptible Risk Factors for Antituberculosis (ATT) Induced Hepatitis | Biotech Hunter | Biotech Hunter